Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H40N2.2BrH |
Molecular Weight | 518.412 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.Br.[H][C@]12CC[C@@]3([H])[C@]4([H])CC=C5C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]13CN(C)[C@H]2C)N(C)C
InChI
InChIKey=YYTFAPMEQOGSRL-VEOCRSHVSA-N
InChI=1S/C24H40N2.2BrH/c1-16-20-8-9-22-19-7-6-17-14-18(25(3)4)10-12-23(17,2)21(19)11-13-24(20,22)15-26(16)5;;/h6,16,18-22H,7-15H2,1-5H3;2*1H/t16-,18-,19+,20+,21-,22-,23-,24-;;/m0../s1
Conessine is a plant steroid alkaloid that acts as a potent and specific antagonist of histamine H3 receptors. Conessine displayed high affinity at both rat and human H3 receptors (pKi = 7.61 and 8.27) and generally high selectivity against other sites, including histamine receptors H1, H2, and H4. Conessine was found to efficiently penetrate the CNS and reach very high brain concentrations. Although the very slow CNS clearance and strong binding to adrenergic receptors discouraged focus on conessine itself for further development, its potency and novel steroid-based skeleton motivated further chemical investigation. Modification based on introducing diversity at the 3-nitrogen position generated a new series of H3 antagonists with higher in vitro potency, improved target selectivity, and more favorable drug-like properties. Conessine also has high affinity for the adrenergic receptors. Conessine has being shown to possess anti-malarial activity. In India conessine finds therapeutic use for treatment of dysentery and helminthic disorders.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL264 |
8.27 null [pKi] | ||
Target ID: CHEMBL1867 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18683917 |
6.18 null [pKi] | ||
Target ID: CHEMBL364 |
1.04 µM [IC50] | ||
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22569298 |
21.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23758861
Mice: Conessine significantly reduced parasitaemia (at 10 mg/kg exhibited 88.95% parasite inhibition) in P. berghei-infected mice. Conessine was administered orally to mice of different groups for four days
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23758861
Conessine showed in vitro anti-plasmodial activity with its IC₅₀ value 1.9 ug/ml and 1.3 ug/ml using schizont maturation and pLDH assay respectively. The compound showed cytotoxity IC₅₀= 14 ug/ml against L6 cells of rat skeletal muscle myoblast.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C221
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID30974568
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
111109
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
CHEMBL191703
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
C79872
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
5913-82-6
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
N9EQE108I5
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | |||
|
m3750
Created by
admin on Fri Dec 15 17:42:00 GMT 2023 , Edited by admin on Fri Dec 15 17:42:00 GMT 2023
|
PRIMARY | Merck Index |
ACTIVE MOIETY
SUBSTANCE RECORD